| Form | Liquid |
|---|
| Clonality | Monoclonal |
|---|
| Isotype | (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-( |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Species Reactivity | Human |
|---|
| Target | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homo |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | P15391 & Q9NZQ7 & P07766 & Q07011 |
|---|
| Background | Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody.
|
|---|
| Alternative Names | GNC038, GNC-038, GNC038, 2559704-23-1 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|